Parametrica Management Ltd FATE FATE THERAPEUTICS INC

Ownership history in Parametrica Management Ltd  ·  19 quarters on record

AI Ownership Summary

Parametrica Management Ltd reported FATE THERAPEUTICS INC (FATE) in 19 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.2% in 2024 Q1. The latest visible filing shows FATE at 0.03% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this FATE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Parametrica Management Ltd's position in FATE THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

FATE was reported at 0.03% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.2% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Parametrica Management Ltd held FATE — position size vs. price
% of Fund (quarterly)    FATE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 18,472 0% 0.03% $18K 2026-02-14 (Est.) $1.25
2025 Q3 UNCHANGED 18,472 0% 0.04% $23K 2025-11-12 $1.04
2025 Q2 UNCHANGED 18,472 0% 0.04% $21K 2025-08-11 $0.94
2025 Q1 UNCHANGED 18,472 0% 0.02% $15K 2025-05-08 $1.03
2024 Q4 UNCHANGED 18,472 0% 0.04% $30K 2025-02-12 $1.25
2024 Q3 UNCHANGED 18,472 0% 0.08% $65K 2024-11-05 $2.68
2024 Q2 UNCHANGED 18,472 0% 0.08% $61K 2024-08-08 $3.62
2024 Q1 UNCHANGED 18,472 0% 0.20% $136K 2024-05-10 $4.08
2023 Q4 UNCHANGED 18,472 0% 0.11% $69K 2024-02-02 $6.52
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Parametrica Management Ltd and FATE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Parametrica Management Ltd reported owning FATE?

Parametrica Management Ltd reported FATE across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported FATE position in Parametrica Management Ltd's portfolio?

The largest reported portfolio weight for FATE was 0.20% in 2024 Q1.

What is the latest reported FATE position on this page?

The most recent filing on this page is 2025 Q4, when Parametrica Management Ltd reported 18,472 shares, equal to 0.03% of portfolio, with an estimated market value of $18K.

What does the chart on this FATE ownership page compare?

The chart compares Parametrica Management Ltd's quarterly FATE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Parametrica Management Ltd time their FATE position?

Based on 13F filing dates vs. subsequent FATE price moves, Parametrica Management Ltd correctly timed 3 out of 8 reported position changes (38%). The annualised alpha on FATE relative to SPY over the holding period was -63.0%.

← Back to Parametrica Management Ltd Holdings